Cite

HARVARD Citation

    Warmuth, S. et al. (2021). Engineering of a trispecific tumor-targeted immunotherapy incorporating 4-1BB co-stimulation and PD-L1 blockade. Oncoimmunology. p. . [Online]. 
  
Back to record